The most crucial goal was to identify acceptable analytical targets by analyzing human hepatocyte incubation samples with substantial-resolution mass spectrometry (HRMS) and to verify the final results in genuine urine specimens and to find out AB-FUBINACA's metabolic stability in human liver microsomes and compared hepatocyte and urine results wit